DIH Holdings US, Inc Class A (DHAI)
OTHER OTC:DHAI
Want to see DHAI full AI Analyst Report?
Top Page
DIH Holdings US, Inc Class A
(OTC:DHAI)
Select Model
Select Model
Rating:42Neutral
Price Target:
$0.03
▼(-3.33% Downside)
Action:Upgraded
Date:03/24/26
The score is driven primarily by weak financial performance—persistent and widening losses, a return to negative operating/free cash flow in 2025, and an ongoing negative equity position that elevates funding risk. Valuation is not meaningfully attractive due to negative earnings (negative P/E), and technical strength cannot be assessed with the missing indicator data.
Positive Factors
Strong gross margins
Gross margins in the low-50% range provide a durable cushion versus peers and input cost swings. Strong unit economics mean the business can reach operating profitability if SG&A and R&D spend are reined in, supporting margin sustainability over months.
Negative Factors
Consistently negative stockholders' equity
A persistent negative shareholders' equity position is a structural solvency concern that limits borrowing capacity, weakens creditor confidence, and heightens refinancing and covenant risk. This condition materially reduces financial flexibility absent a capital raise or sustained profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong gross margins
Gross margins in the low-50% range provide a durable cushion versus peers and input cost swings. Strong unit economics mean the business can reach operating profitability if SG&A and R&D spend are reined in, supporting margin sustainability over months.
Read all positive factors
DIH Holdings US, Inc Class A (DHAI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$62.78K
Dividend YieldN/A
Average Volume (3M)1.62M
Price to Earnings (P/E)―
Beta (1Y)-19.33
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees178
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-6.07
Shares Outstanding2,092,653
10 Day Avg. Volume1,785,620
30 Day Avg. Volume1,620,579
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-0.22
Price to Sales (P/S)0.13
P/FCF Ratio-1.77
Enterprise Value/Market Cap160.62
Enterprise Value/Revenue0.16
Enterprise Value/Gross Profit0.31
Enterprise Value/Ebitda-1.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DIH Holdings US, Inc Class A Business Overview & Revenue Model
Company Description
DIH Holding US, Inc. operates as a robotics and virtual reality technology provider in the rehabilitation and human performance industry. The company is based in Norwell, Massachusetts....
How the Company Makes Money
null...
DIH Holdings US, Inc Class A Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | Mar 2025 | Jun 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 62.86M | 64.47M | 55.00M | 49.04M | 47.52M |
| Gross Profit | 32.21M | 29.77M | 34.54M | 24.77M | 28.23M |
| EBITDA | -7.11M | -6.20M | 652.00K | -7.88M | -9.63M |
| Net Income | -8.68M | -8.44M | -2.36M | -12.05M | -10.85M |
Balance Sheet | |||||
| Total Assets | 26.75M | 35.73M | 35.73M | 34.02M | 38.78M |
| Cash, Cash Equivalents and Short-Term Investments | 1.94M | 3.23M | 3.23M | 3.31M | 3.16M |
| Total Debt | 11.96M | 15.95M | 15.95M | 23.63M | 17.09M |
| Total Liabilities | 63.89M | 68.28M | 68.28M | 60.44M | 54.96M |
| Stockholders Equity | -37.13M | -32.55M | -32.55M | -26.42M | -16.18M |
Cash Flow | |||||
| Free Cash Flow | -4.68M | 4.99M | 6.02M | -1.71M | -5.74M |
| Operating Cash Flow | -4.14M | 5.19M | 6.18M | -744.00K | -4.99M |
| Investing Cash Flow | -536.00K | -202.00K | -163.00K | -969.00K | -1.12M |
| Financing Cash Flow | 3.39M | -4.95M | -3.66M | 2.04M | 2.16M |
DIH Holdings US, Inc Class A Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | $7.97M | -0.59 | -268.55% | ― | 39.98% | 90.08% | |
45 Neutral | $39.64M | ― | -9999.00% | ― | -95.74% | -118.94% | |
43 Neutral | $6.95M | -1.19 | -84.30% | ― | -23.81% | 32.96% | |
42 Neutral | $62.78K | >-0.01 | ― | ― | ― | ― | |
42 Neutral | $718.36K | 31.98 | -476.74% | ― | -8.54% | 40.91% | |
39 Underperform | $5.92M | -1.29 | -220.42% | ― | ― | 51.71% |
* Healthcare Sector Average
DHAI
DIH Holdings US, Inc Class A
0.03
-5.82
-99.49%
SSKN
Strata Skin Sciences
0.16
-2.25
-93.40%
BMRA
Biomerica
2.38
-1.26
-34.62%
PAVM
PAVmed
6.40
-12.50
-66.14%
TNON
Tenon Medical, Inc.
0.70
-0.47
-40.26%
HSCS
Heart Test Laboratories, Inc.
1.88
-2.61
-58.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.